This research, part of the NIH’s RECOVER Initiative, provides a large-scale look at how SARS-CoV-2 infection impacts the "long tail" of healthcare for children already managing chronic medical conditions (CMCs). By analyzing electronic health records (EHR) from over 78,000 children, the study reveals that a COVID-19 diagnosis is associated with a significant, sustained increase in healthcare utilization—most notably a doubling of inpatient hospitalizations—in the months following the initial infection.
TL;DR
Children with pre-existing chronic conditions who contract COVID-19 utilize healthcare services at significantly higher rates in the post-acute period (28+ days later) compared to matched peers. The most dramatic increase is seen in inpatient care, where utilization rates more than double, particularly for those who had moderate to severe initial infections.
What Problem Does This Paper Address?
While it is well-established that children with chronic medical conditions (CMCs)—such as asthma, diabetes, or sickle cell disease—are at higher risk for severe acute COVID-19, much less is known about the "post-acute" phase.
The researchers sought to answer a critical question: Does a SARS-CoV-2 infection disrupt the management of a child’s underlying chronic disease? If the infection triggers flare-ups or new complications (Post-Acute Sequelae of SARS-CoV-2, or PASC), it should manifest as increased healthcare utilization (doctor visits, ER trips, and hospital stays) even after the initial virus has cleared.
Methods
The authors conducted a retrospective, matched-cohort study using data from PEDSnet, a national network of eight major pediatric health systems.
- Cohorts: They compared a "COVID-positive" cohort (children with a positive PCR/antigen test or specific diagnosis codes) to a "comparison" cohort (those with only negative tests or no evidence of infection).
- Matching: To ensure a fair comparison, they used a stratified propensity score model. This matched patients based on age, race/ethnicity, specific chronic condition clusters, baseline healthcare use, and even the month of entry to account for different viral variants (like Delta vs. Omicron).
- Analysis: They employed a negative binomial model to calculate Utilization Rate Ratios (URR) for the period starting 28 days after the initial infection through the end of the follow-up.
Datasets
The study utilized the PEDSnet COVID-19 Database, which standardizes EHR data across institutions including CHOP, Cincinnati Children’s, Stanford, and others.
- Total Patients Identified: 748,692 children with at least one chronic condition.
- COVID-19 Cohort: 78,744 patients.
- Comparison Cohort: 478,674 patients.
- Timeline: Data spanned March 1, 2020, to February 28, 2022.
Key Insights and Ideas
- The Inpatient Surge: The most striking finding was that the increase in utilization wasn't just for routine check-ups. The URR for inpatient care was 2.03, meaning COVID-positive children with CMCs were twice as likely to be hospitalized in the post-acute period than their uninfected peers.
- Severity Correlation: There is a clear "dose-response" relationship. Children who had severe or moderate acute COVID-19 saw much higher post-acute utilization (URR ~3.7 for inpatient care) than those with mild or asymptomatic cases.
- The "Caution" Hypothesis: The authors suggest that some increased utilization might stem from "provider caution." Because the long-term effects of COVID-19 are poorly understood, doctors may be more likely to admit or closely monitor a child with a chronic condition out of an abundance of caution.
- Broad Impact: While the study looked at CMCs as a whole, the increased utilization was observed across various condition clusters, suggesting the virus's impact is systemic rather than limited to respiratory issues.
Key Results
- Overall Utilization: The COVID-positive cohort had a 21% higher rate of total healthcare visits (URR 1.21; 95% CI: 1.18-1.24).
- Setting-Specific Ratios:
- Inpatient: 2.03 (The highest increase).
- Emergency Department (ED): 1.54.
- Outpatient: 1.15.
- Absolute Difference: The model estimated 3.00 visits/year for the COVID-positive group vs. 2.48 for the comparison group—an absolute difference of roughly one extra visit every two years per child.
- Time to First Visit: Hazard ratios mirrored these results, showing that COVID-positive children returned to the hospital or ER significantly sooner than the comparison group.
Limitations and Future Work
- Data Fragmentation: EHR data is limited to the participating health systems; if a child visited an outside urgent care or hospital, that data was missed.
- Causality vs. Environment: It remains difficult to disentangle whether the increased care is due to the biological pathology of the virus or the general stress and changes in care delivery caused by the pandemic environment.
- Heterogeneity of CMCs: This study grouped many different conditions together. The authors emphasize that condition-specific research is the necessary next step to see if, for example, the "post-COVID spike" looks different for a child with Type 1 Diabetes versus one with Congenital Heart Disease.
- PASC Definition: The study measures utilization as a proxy for health, but it doesn't definitively categorize these visits as "Long COVID" (PASC) versus an exacerbation of the original chronic condition.
Summary updated